학술논문
EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF ORALLY ADMINISTERED BI 409306, A NOVEL PHOSPHODIESTERASE 9 INHIBITOR, IN TWO RANDOMIZED CONTROLLED PHASE II STUDIES IN PATIENTS WITH PRODROMAL AND MILD ALZHEIMER’S DISEASE
Document Type
Abstract
Author
Source
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2018 14(7) Supplement:P249-P250
Subject
Language
ISSN
1552-5260